
International
Report on the jointly organized event "From research to sovereign readiness against CBRN and health threats"
Health and safety: Institut Pasteur involved in European dialog in Brussels
On November 3, the Institut Pasteur joined forces with the French Alternative Energies and Atomic Energy Commission (CEA), Inserm, the Institute for Strategic Research at the Military School (IRSEM) and the French Authority for Nuclear Safety and Radiation Protection (ASNR) to organize a strategic meeting at Maison Irène et Frédéric Joliot-Curie in Brussels on the topic "Europe's strategic health power: From research to sovereign readiness against CBRN (Chemical, Biological, Radiological, Nuclear) and health threats." The event, held during the European Union's negotiations on the next multiannual financial framework and European programs for the period 2028-2034, was attended by scientists from research organizations involved in leading European projects as well as representatives of Member States and the European institutions, including various European Commission Directorates-General (DG SANTE, HERA, ECHO and DEFIS) and the European Medicines Agency (EMA).
At a time of growing geopolitical tension, resilience and preparedness for crises, including health crises, are recognized as priorities. DG HERA (the EU's Health Emergency Preparedness and Response Authority) has strengthened its position on biological risks as part of the EU's Preparedness Union Strategy.
Stakeholders all agree that Europe is by no means lacking in scientific excellence. The challenge is to convert this excellence into deployable capabilities: ongoing funding, clear regulatory pathways, the ability to anticipate and produce medical countermeasures, stockpiles of appropriate equipment, and civilian and military cooperation. In a complex world, the advantage comes through the ability to connect knowledge in different fields.
The Institut Pasteur made an active contribution to the discussions by presenting one of the strategic European projects on health security and addressing CBRN threats in which it is involved: the RESILIENCE alliance, supported by the European Defence Fund. The roadmap for the next stage of the project, RESILIENCE 2.0, is currently being discussed at the European level. The Yersinia Unit within the Department of Microbiology, led by Javier Pizarro-Cerdà, which works in close collaboration with the CEA, was represented by Christian Demeure and Olivier Dussurget. The unit combines basic research, the development of solutions (including a vaccine candidate for plague) and public health missions related to pathogenic Yersinia species, including the causative agent for plague (Y. pestis). In France, it serves as the National Reference Laboratory and is part of the French surveillance network for enteropathogenic Yersinia. On the international front, it is a WHO Collaborating Center for Yersinia.
The event also highlighted the ethical challenges raised by dual-use research of this kind and the need for a strict framework, transparency and democratic control. Fanny Momboisse, who coordinates the Dual-Use Liaison Group within the Legal Affairs Department, took part in the round table on "Governing strategic health power legitimately." The discussions highlighted the fact that the academic community is often unaware of these issues and pointed to the need to raise awareness. The question is particularly topical since the European Commission's proposal for the next framework program (Horizon Europe 2028-2034) will authorize funding for dual-use research for the first time, while retaining a primarily civilian focus. Negotiations on this matter are ongoing.
The question of animal testing, which is crucial in demonstrating the efficacy of medical countermeasures but remains a sensitive issue for the public, was also addressed. Simplifying should not mean lowering requirements.
A summary report entitled "European technological sovereignty and strategic health power: from research to sustained health protection" is currently being drafted and will be followed by a scientific publication coordinated by research institutes involved in these challenges.
Contributors from the Institut Pasteur
- Javier Pizarro-Cerdà, Christian Demeure, Olivier Dussurget, Yersinia Research Unit
- Fanny Momboisse, Legal Affairs Department
- Nazaré Guimard, Emilia Didier, Emilien Stragier, Grants Office